 |
|
|
| |
Determinants of Variability in ISG15 Gene Expression in Patients With Chronic Hepatitis B (CHB) Infection During Treatment With Oral TLR-7 Agonist GS-9620
|
| |
| |
Reported by Jules Levin
EASL 2014 April 9-13 London, UK
Edward J. Gane,1 Stuart C. Gordon,2 Shyamasundaran Kottilil,3 Benedetta Massetto,4 Anuj Gaggar,4 Scott Stem,4 Stefan Pflanz,4 Zhishen Ye,4 G. Mani Subramanian,4 John G. McHutchison,4 Young-Suk Lim,5 Yoon Jun Kim6
1Auckland Clinical Studies, Auckland, New Zealand; 2Henry Ford Health Systems, Detroit, Michigan, USA; 3National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA; 4Gilead Sciences, Inc., Foster City, California, USA; 5Asan Medical Center, Seoul, South Korea; 6Seoul National University Hospital, Seoul, South Korea
|
| |
|
|
|
|
|
